HCV Infection - The Silent Spread
- Transmission: Primarily IV drug use, blood products (pre-1992), needle-stick.
- Clinical Course: Often asymptomatic for decades, allowing for spread.
⭐ Extrahepatic Manifestations: Mixed cryoglobulinemia is a classic association, presenting with palpable purpura, arthralgias, and neuropathy.

Acute vs Chronic HCV - The Great Divergence
- Initial exposure to HCV leads to acute infection. The clinical course then diverges, with most individuals progressing to chronic disease.
- Acute Phase: Often asymptomatic (>80%). Spontaneous viral clearance occurs in only ~20-40% of patients.
- Chronic Phase: The majority (~60-80%) fail to clear the virus. This phase is typically a slow, insidious progression over decades.

⭐ Most patients with chronic HCV are asymptomatic for decades, earning it the name "silent epidemic." Co-infection with HIV or alcohol use significantly accelerates fibrosis progression to cirrhosis.
Chronic Complications - The Liver's Long Road
- Cirrhosis & Decompensation: Develops in ~20% of patients over 20-30 years, leading to portal hypertension and hepatic failure (ascites, variceal bleeding, encephalopathy).
- Hepatocellular Carcinoma (HCC): Significantly ↑ risk, especially with established cirrhosis. Regular surveillance with ultrasound is recommended.
- Extrahepatic Manifestations: Immune complex deposition is a key mechanism.
- Mixed Cryoglobulinemia: Systemic vasculitis. 📌 HCV = Heavy Cryo Vasculitis.
- Glomerulonephritis: Most commonly Membranoproliferative Glomerulonephritis (MPGN).
- Porphyria Cutanea Tarda: Photosensitive skin lesions.
- Lichen Planus.
⭐ Mixed cryoglobulinemia is a classic extrahepatic finding, presenting as a triad of palpable purpura, arthralgias, and weakness (Meltzer's triad).
Extrahepatic Disease - Beyond the Liver
HCV infection is a systemic disease with numerous immune-mediated extrahepatic manifestations, often preceding liver-related symptoms.
- Mixed Cryoglobulinemia (Types II & III): The most classic finding.
- Immune complexes (IgM, HCV RNA) deposit in small vessels.
- Presents with Meltzer's Triad: palpable purpura, arthralgias, weakness.
- Renal Disease:
- Membranoproliferative glomerulonephritis (MPGN) is the hallmark, often secondary to cryoglobulinemia.
- Dermatologic:
- Porphyria cutanea tarda (PCT)
- Lichen planus
- Hematologic:
- Increased risk of B-cell non-Hodgkin lymphoma (NHL).

⭐ Mixed cryoglobulinemia vasculitis is the most tested extrahepatic manifestation of chronic HCV.
High‑Yield Points - ⚡ Biggest Takeaways
- HCV has a >80% rate of progressing to chronic infection, unlike HBV.
- Acute HCV is typically asymptomatic; most individuals are unaware of the initial infection.
- Of those with chronic infection, ~20-30% will develop cirrhosis over 20-30 years.
- Cirrhosis is the primary risk factor for developing hepatocellular carcinoma (HCC).
- Key extrahepatic manifestations include mixed cryoglobulinemia, membranoproliferative glomerulonephritis, and porphyria cutanea tarda.
- IV drug use remains the most common mode of transmission.
Continue reading on Oncourse
Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.
CONTINUE READING — FREEor get the app